(Circulation. 2004;109:664-670.)
© 2004 American Heart Association, Inc.
Basic Science Reports |
From the Cardiovascular Research Institute and Department of Medical Physiology, Texas A&M University System Health Science Center (J.A.F., M.L.M., J.L.P.), and Department of Health and Kinesiology (J.M.M.-D., M.D.D.), Texas A&M University, College Station, Tex, and Dalton Cardiovascular Research Center and Departments of Physiology and Biomedical Sciences, University of Missouri, Columbia (M.H.L.).
Correspondence to Janet L. Parker, Cardiovascular Research Institute and Department of Medical Physiology, TAMUS HSC MS 1114, College Station, TX 77843-1114. E-mail jlp{at}tamu.edu
Received December 30, 2002; de novo received May 9, 2003; revision received October 3, 2003; accepted October 6, 2003.
| Abstract |
|---|
|
|
|---|
Methods and Results The proximal left circumflex coronary artery (LCx) of female Yucatan miniswine was surgically instrumented with an ameroid occluder to induce CCO; 8 weeks after surgery, animals were randomized into 14-week sedentary (SED) or EX (treadmill; 5 d/wk) protocols. Coronary arterioles (
100 µm in diameter) were isolated from collateral-dependent (LCx) and nonoccluded (left anterior descending; LAD) perfused myocardium of SED and EX animals. Vasodilation was assessed by videomicroscopy and MacLab data acquisition. Responses to VEGF165 were unaffected by EX in nonoccluded LAD arterioles; in contrast, EX markedly enhanced VEGF165-induced vasodilation of collateral-dependent LCx arterioles (P<0.05; EX versus SED). Furthermore, VEGF165-induced vasodilation of EX LCx arterioles exceeded that of EX or SED LAD arterioles (P<0.05). Enhanced vasodilation of EX LCx arterioles was abolished by inhibition of NO synthase and tyrosine kinase activity. Combined inhibition of NO synthase and cyclooxygenase decreased VEGF165-induced vasodilation of all vessels.
Conclusions EX enhances VEGF165-induced vasodilation in arterioles distal to CCO; EX effects seem to be mediated through increases in NO.
Key Words: microcirculation nitric oxide occlusion coronary disease collateral circulation
| Introduction |
|---|
|
|
|---|
Interestingly, long-term exercise training (EX) has been shown to ameliorate endothelial dysfunction via undefined mechanisms.1012 In normal pigs, ecNOS mRNA of coronary arterioles is upregulated by EX.13 Griffin et al10 recently reported that impaired microvascular responsiveness to bradykinin in porcine CCO is reversed by EX and that the occlusion-related reduction of ecNOS mRNA in arterioles is prevented or reversed by EX. These results indicate that EX-induced increases in production and/or stabilization of NO may contribute to improved coronary microvascular function in the CCO model.10
In addition, EX increases VEGF protein expression in normally perfused muscle14 and increases VEGF mRNA in a model of femoral ligation.15 Exercise-induced increases in VEGF mRNA and protein in muscle have also been demonstrated in heart failure patients.16 Importantly, because the effects of VEGF on vasodilation, angiogenesis, and collateral development are believed to involve NO production,1719 we hypothesized that EX enhances VEGF-mediated vasodilation in collateral-dependent coronary arterioles and that enhanced VEGF responses are mediated by the effects of NOS and NO production.
| Methods |
|---|
|
|
|---|
Training Procedures
After 8 weeks of postoperative recovery, pigs were randomly assigned to sedentary (SED; n=29) or exercise training (EX; n=33) groups. Animals were fed once daily and allowed water ad libitum. SED animals remained confined to pens. EX animals were exposed to a 14-week treadmill program used extensively by this laboratory and others.1012,22
Isolated Microvessel Preparation
After completion of the protocols, animals were anesthetized, the heart was removed, and transmural tissue samples were dissected from collateral-dependent myocardium and myocardium perfused by the unoccluded left anterior descending (LAD) coronary artery.
Subepicardial arteriolar branches (<150-µm ID; 0.6 to 1 mm axial length) were dissected, and cannulation was performed as described previously by Muller-Delp et al.23 Briefly, arterioles were cannulated in a Lucite chamber with micropipettes, secured with suture, transferred to an inverted microscope (Olympus IX70), and pressurized. Vessels were visualized and assessed via videocamera (Panasonic BP310), CCTV monitor (Panasonic), video micrometer (Microcirculation Research Institute, TAMUSHSC), and a data-acquisition system (Macintosh/MacLab). Vessels were warmed to 37°C and equilibrated for 60 minutes at a static intraluminal pressure of 40 mm Hg.
Training Efficacy/Oxidative Enzyme Capacity
Training efficacy was determined via comparison of skeletal muscle citrate synthase activities11,12,22 and heart-tobody weight ratios between SED and EX animals. Samples of deltoid and triceps brachii were immediately frozen in liquid N2 and stored at -70°C. Citrate synthase activity was determined from whole-muscle homogenate and spectrophotometry.24
Experimental Protocols
Functional assessment to agonist (±inhibitors) was conducted at static pressure with no flow. Arterioles were assessed for generation of spontaneous tone sufficient for vasodilation studies, and if inadequate, endothelin-1 was administered abluminally. Once diameter had stabilized, concentration-response relationships to adenosine (10-10 to 10-4 mol/L) and VEGF165 (10-14 to 10-9 mol/L) (R&D Systems) were determined by cumulative additions.
Freshly prepared arterioles were used to evaluate responses to VEGF165 in the presence of selective inhibitors. Arterioles underwent a 20-minute preincubation with inhibitor and subsequent treatment with endothelin-1 to achieve adequate tone. NG-Monomethyl-L-arginine (L-NMMA; 10 µmol/L; Calbiochem) was used to inhibit NOS, and indomethacin (10 µmol/L) was used to block cyclooxygenase (COX)mediated prostanoid release. Piceatannol (10 µmol/L) was used to inhibit tyrosine kinase activity. At the conclusion of the experiment, nitroprusside (100 µmol/L) was used to determine maximal vessel diameter.
Solutions and Drugs
Chemicals were obtained from Sigma, except as stated. Physiological saline solution (PSS) contained (in mmol/L) NaCl 145, KCl 4.7, CaCl2 2.0, MgSO4 1.17, NaH2PO4 1.2, glucose 5.0, pyruvate 2.0, EDTA 0.02, and MOPS buffer 3.0. All solutions were adjusted to pH 7.4. VEGF165 was prepared in PSS with albumin (USB/Amersham). L-NMMA and indomethacin were prepared in PSS. Piceatannol was dissolved in DMSO as a stock solution, and dilutions were in PSS.
Data Analysis
Citrate synthase activity of skeletal muscle and heart-tobody weight ratios were compared by Students unpaired t test. Vasodilator responses were expressed as percentage of maximal diameter. Concentration-response curves were compared by 2-way ANOVA for repeated measures with Fishers test for least significant difference (LSD). For all analyses, significance is defined as a value of P
0.05. Data are represented as mean±SEM. Animal numbers are in parentheses.
| Results |
|---|
|
|
|---|
|
Vessel Characteristics
Lumen diameter, percent preconstriction, and concentration of endothelin-1 used were similar between LAD and LCx arterioles from EX and SED animals (Table 2).
|
Vasodilation Response to VEGF165
Collateral-dependent LCx arterioles from EX animals displayed significantly enhanced VEGF165-induced vasodilation compared with LCx arterioles from SED animals and nonoccluded LAD arterioles from SED and EX animals (P<0.05; Figure 1). VEGF165 produced similar concentration-dependent vasodilation of SED and EX LAD arterioles. SED LCx arterioles did not display an attenuated VEGF165-induced vasodilation, as demonstrated by comparison with SED LAD. Both occlusion and EX seem to be necessary to produce an enhanced vasodilation to VEGF165, as shown in Figure 1. On removal of VEGF, tone in these arterioles recovered to levels not different from initial tone (data not shown).
|
Role of NO in EX-Induced, Enhanced Response to VEGF165
NOS inhibition (L-NMMA; 10 µmol/L) decreased the maximal VEGF165-induced dilation but did not significantly reduce the overall vasodilation of EX LAD arterioles. In addition, LAD arterioles from EX and SED animals responded similarly to VEGF165 in the presence of L-NMMA (Figure 2). L-NMMA significantly reduced vasodilation of EX LCx arterioles to VEGF165, indicating a potential role for enhanced NO production after EX, but did not significantly affect SED LCx arterioles (Figure 2). Importantly, L-NMMA abolished the enhanced vasodilation of EX LCx arterioles, as demonstrated by comparison of EX and SED LCx. Substantial VEGF165-induced vasodilation remained after NOS inhibition in all arterioles.
|
Role of Prostanoid Vasodilators in VEGF165-Induced Dilation
Combined inhibition of NOS (L-NMMA; 10 µmol/L) and COX (indomethacin; 10 µmol/L) did significantly inhibit VEGF165-induced vasodilation of EX LAD arterioles. However, dual blockade did not significantly inhibit response of SED LAD arterioles (Figure 3). Vasodilation of SED and EX LCx arterioles to VEGF165 was significantly reduced by inhibition of NOS and COX; EX LCx arterioles were more profoundly affected (Figure 3). Combined inhibition did not abolish the vasodilation response to VEGF165.
|
Role of Tyrosine Kinase Activity in VEGF165-Induced Dilation
Vasodilation of SED LAD and LCX arterioles and that of EX LAD arterioles were similarly diminished by tyrosine kinase inhibition (piceatannol; 10 µmol/L) (Figure 4). VEGF165-induced vasodilation of SED LCx arterioles seemed to be unaffected by piceatannol (Figure 4). Importantly, vasodilation of EX LCx arterioles was significantly diminished by piceatannol; indeed, vasodilation was no longer enhanced (EX versus SED).
|
Vascular Smooth Muscle Responses
Sodium nitroprusside (100 µmol/L) was used to establish maximal diameter and vascular smooth muscledependent vasodilation. Responses were not different between vessels (not shown). In addition, adenosine produced responses that were not different in LAD and LCx arterioles from SED and EX animals (Figure 5) and were unaffected by L-NMMA (not shown).
|
| Discussion |
|---|
|
|
|---|
Vasodilation to VEGF165
VEGF plays a significant role in angiogenesis and collateral development in coronary and peripheral vascular occlusive diseases.18,19 In the present study, CCO combined with EX resulted in enhanced vasodilation of isolated coronary arterioles to VEGF165. After training, vasodilation of collateral-dependent LCx arterioles exceeded that of LCx arterioles from SED animals and nonoccluded LAD arterioles (SED and EX). We believe that enhanced vasodilation after training in arterioles subjected to CCO may imply an increased role of VEGF165 in ongoing collateral development in our model. Furthermore, previous studies have established that training increases release of VEGF and VEGF receptor mRNA expression in ischemic muscle.15 Taken together, these data imply a synergistic environment in collateral-dependent myocardium of EX animals because of increased VEGF and enhanced microvascular sensitivity to VEGF.
Sellke et al25 reported enhanced responses to VEGF in coronary arterioles of untrained animals exposed to chronic occlusion. Explanations for discrepancies with our findings in SED animals are unclear. However, Sellke et al performed studies 7 to 9 weeks after instrumentation,25 whereas our study assessed function 22 weeks after ameroid placement. Collateral development at 8 weeks in this model provides adequate blood flow in resting myocardium20,21 but insufficient flow during physiological stress.3,20,21 Possibly, at 7 to 9 weeks, collateral development may be more limited than at 22 weeks, inadequately perfusing "resting" myocardium and potentially causing variable ischemic episodes stimulating enhanced VEGF-induced responses under sedentary conditions.26
VEGF165-Induced Vasodilation: Role of NOS and Cyclooxygenase
VEGF upregulates ecNOS expression and protein,2729 induces production of NO and prostacyclin in endothelial cells,27,3033 and increases circulating endothelial progenitor cells.34 Exercise training induces increases in ecNOS mRNA in normal porcine hearts,13 prevents reduction in ecNOS mRNA in porcine hearts exposed to CCO,10 and induces VEGF release from ischemic muscle.15 Thus, enhanced VEGF165-induced vasodilation after training may result from several underlying mechanisms, including VEGF receptor upregulation, increased ecNOS activity (via ecNOS mRNA/protein upregulation or enhanced Ca2+ mobilization), and/or enhanced VEGF signal transduction in collateral-dependent arterioles. In addition, we speculate that VEGF-induced increases in circulating endothelial progenitor cells may contribute to beneficial reendothelialization of the microvasculature downstream from occlusion.34 These effects may culminate in improved endothelial function; increased endothelial production of NO, which mediates vasodilation35; increased blood flow; and the angiogenic process.27,30 This explanation is substantiated by NOS inhibition abolishing EX-induced enhanced vasodilation of collateral-dependent arterioles to VEGF165 (Figure 2). Interestingly, NOS inhibition did not significantly affect VEGF165-induced vasodilation of collateral-dependent arterioles from SED animals and minimally affected normally perfused arterioles from SED and EX animals. Therefore, NO may play a greater role in VEGF-mediated vasodilation after training compared with responses observed in SED animals. Also, although lack of NOS blockade by L-NMMA could theoretically contribute to our results in SED LCx arterioles, we believe that this possibility is unlikely. Hein and Kuo36 demonstrated that L-NMMA (10 µmol/L) significantly inhibits agonist-stimulated NO production in porcine coronary arterioles. Furthermore, 10 µmol/L L-NMMA does not affect basal diameter or basal NO release37 measured in isolated arterioles and is without nonspecific smooth muscle effects observed at higher concentrations.38 Nonetheless, our findings prompted experiments to further define the mechanisms by which VEGF165 caused vasodilation in coronary arterioles from our model.
VEGF stimulates production of NO and prostacyclin, which increase vessel permeability, induce endothelial cell proliferation and migration,30,39,40 and cause vasodilation25 and hypotension.35 In agreement, we found that both NO- and COX-mediated vasodilators contribute to VEGF165-induced vasodilation. Combined inhibition of NOS and cyclooxygenase significantly impaired vasodilation of collateral-dependent arterioles from EX and SED animals (Figure 3). However, the combined results of Figures 2 and 3
indicate that the relative contribution of NO to VEGF relaxation dominates in LCx arterioles from EX animals, whereas COX-mediated vasodilators play an increased role in LAD arterioles from SED and EX animals and LCx arterioles from SED animals. Interestingly, combined inhibition did not completely abolish the VEGF165-induced vasodilation, which suggests that unidentified vasoactive substances may be released in response to VEGF165 and contribute to vasodilation. A prime candidate is endothelial hyperpolarizing factor, although methods to establish its role were not used.
VEGF165-Induced Vasodilation: Role of Tyrosine Kinases
VEGF is believed to confer its major effects via tyrosine kinase receptors.41 Therefore, inhibition of tyrosine kinase activity should abolish VEGF intracellular signaling and production of vasoactive substances. In our preparation, tyrosine kinase inhibition significantly reduced vasodilation of collateral-dependent arterioles from EX animals and abolished the effects of training on VEGF165 response (Figure 4). However, collateral-dependent arterioles from SED animals seemed to be unaffected by piceatannol. Reversal of the training effect strongly implies a role of tyrosine kinase activation in training-induced enhancement of VEGF165-induced vasodilation and NO production. To the best of our knowledge, this is the first report that the effects of exercise training in experimental coronary disease involve alterations in VEGF signaling mechanisms such as tyrosine kinase pathways. Interestingly, tyrosine kinase inhibition did not completely abolish vasodilation to VEGF165. This finding is in agreement with previous reports using porcine coronary arterioles25 and implies that VEGF165 may induce release of vasodilators through signaling cascades other than activation of tyrosine kinases.
Vascular Smooth Muscle Responses
Theoretically, training-induced enhanced vasodilation to VEGF could result from increased responsiveness of coronary microvascular smooth muscle. However, unlike vasodilation to VEGF, smooth muscle responses to nitroprusside10 (an NO donor) and adenosine (present study) in arterioles from EX and SED animals are unaffected by either CCO or training. These studies provide important controls for VEGF responses and indicate that arteriolar smooth muscle responses to NO and adenosine and downstream cGMP/cAMP mechanisms are unaltered and do not contribute to enhanced VEGF relaxation after training.
| Conclusions and Implications |
|---|
|
|
|---|
Increased NO production after training implies other beneficial effects of NO present in diseased myocardium, including reduction in platelet adhesion and aggregation, thrombogenicity, and vasospasm, as well as increased angiogenesis and optimized collateralization. We recognize the difficulties of extrapolating these in vitro findings to the intact heart under conditions of varying coronary flow. However, we speculate that these positive effects of exercise training on VEGF/NO responses may potentially contribute to improved perfusion of collateral-dependent myocardium and may be involved in improved myocardial function and enhanced coronary vasodilator reserve of collateral-dependent myocardium observed after long-term exercise in a similar porcine model of CCO.21 Thus, this study further substantiates the beneficial role of exercise training in improving endothelial function and blood flow to the myocardium distal to occlusion. Importantly, these findings also imply endothelium-related mechanisms underlying known beneficial effects of exercise in patients with coronary artery disease as well as reductions in morbidity and mortality associated with improved endothelial function.42,43
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Thengchaisri, R. Shipley, Y. Ren, J. Parker, and L. Kuo Exercise Training Restores Coronary Arteriolar Dilation to NOS Activation Distal to Coronary Artery Occlusion: Role of Hydrogen Peroxide Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 791 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lawler, H.-B. Kwak, W. Song, and J. L. Parker Exercise training reverses downregulation of HSP70 and antioxidant enzymes in porcine skeletal muscle after chronic coronary artery occlusion Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1756 - R1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Heaps, M. L. Mattox, K. A. Kelly, C. J. Meininger, and J. L. Parker Exercise training increases basal tone in arterioles distal to chronic coronary occlusion Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1128 - H1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshinari, H. Yaoita, K. Maehara, and Y. Maruyama Different therapeutic responses to treadmill exercise of heart failure due to ischemia and infarction in rats Cardiovasc Res, February 1, 2005; 65(2): 457 - 468. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |